Pages that link to "Q54132271"

The following pages link to Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. (Q54132271):

Displaying 41 items.

• Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain (Q21561008) (← links)
• Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. (Q26995739) (← links)
• A Y2 receptor mimetic aptamer directed against neuropeptide Y. (Q31033093) (← links)
• Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders? (Q33643154) (← links)
• The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. (Q34130568) (← links)
• Brain neuropeptide Y (NPY) in stress and alcohol dependence (Q34639272) (← links)
• Neuropeptide Y and its receptors as potential therapeutic drug targets (Q34989362) (← links)
• The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review (Q35071470) (← links)
• Alcoholism: allostasis and beyond (Q35073089) (← links)
• Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner (Q35549488) (← links)
• Physiology and gene regulation of the brain NPY Y1 receptor (Q36600471) (← links)
• Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors (Q36733699) (← links)
• NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons (Q36850591) (← links)
• Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non-ethanol-abstinent, Wistar rats. (Q37030341) (← links)
• Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. (Q37794546) (← links)
• Both overexpression of agouti-related peptide or neuropeptide Y in the paraventricular nucleus or lateral hypothalamus induce obesity in a neuropeptide- and nucleus specific manner (Q37826475) (← links)
• Central functions of neuropeptide Y in mood and anxiety disorders (Q37945311) (← links)
• Neuropeptide Y in Alcohol Addiction and Affective Disorders (Q38616747) (← links)
• Central nervous system pharmacology of neuropeptide Y (Q40465108) (← links)
• Novel cell line selectively expressing neuropeptide Y-Y2 receptors (Q40593925) (← links)
• Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models (Q41277218) (← links)
• Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. (Q41865328) (← links)
• Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease. (Q42437200) (← links)
• Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats (Q43567210) (← links)
• Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats (Q43798703) (← links)
• Overlapping peptide control of alcohol self-administration and feeding (Q44867669) (← links)
• Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling (Q46248439) (← links)
• Prenatal exposure to betamethasone decreases anxiety in developing rats: hippocampal neuropeptide y as a target molecule (Q46890923) (← links)
• Viral mediated neuropeptide Y expression in the rat paraventricular nucleus results in obesity (Q46959016) (← links)
• Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity (Q47644797) (← links)
• Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat. (Q48290996) (← links)
• Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen (Q48394694) (← links)
• The behavioural effects of neuropeptide Y (NPY) injection into the rat brain frontal cortex (Q48511820) (← links)
• Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation (Q48525452) (← links)
• Inhibitory effect of intrahippocampal NPY injection on amphetamine-induced behavioural activity (Q49127106) (← links)
• Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat (Q49143985) (← links)
• Behavioural profile of a new mouse model for NPY deficiency (Q50784406) (← links)
• Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively (Q52071642) (← links)
• Effects of centrally administered neuropeptide Y (NPY) and NPY13?36 on the brain monoaminergic systems of the rat (Q60732994) (← links)
• Increases in sucrose consumption, but not ethanol consumption, following ICV NPY administration (Q74014963) (← links)
• Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects (Q77332048) (← links)